# Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.

> **NCT01580345** · PHASE3 · COMPLETED · sponsor: **Centre for Chronic Disease Control, India** · enrollment: 600 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Docosa-hexaenoic acid (DHA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01580345
- **Lead sponsor:** Centre for Chronic Disease Control, India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-12-06
- **Final completion:** 2016-12-09
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580345, "Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01580345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*